Paired Phase II Studies of Erlotinib/Bevacizumab in Advanced Bronchioloalveolar Carcinoma or in Never-Smokers with Advanced Non-Small-Cell Lung Cancer (NSCLC): SWOG S0635 and S0636 Trials

BACKGROUND: Before mutation testing of the epidermal growth factor receptor (EGFR) gene was recognized as highly associated with activity of EGFR tyrosine kinase inhibitors (TKIs), clinically defined patient populations with bronchioloalveolar carcinoma (BAC) and never-smokers were identified as lik...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lung Cancer
Main Authors: West, Howard L., Moon, James, Wozniak, Antoinette J., Mack, Philip, Hirsch, Fred R., Bury, Martin J., Kwong, Myron, Nguyen, Dorothy D., Moore, Dennis F., Miao, Jieling, Redman, Mary, Kelly, Karen, Gandara, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748264/
https://ncbi.nlm.nih.gov/pubmed/28801183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2017.06.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados